Harmony Biosciences Holdings, Inc.
USD36.15
+0.81 (+2.29%)
CEO
Jeffrey Dayno
IPO Date
2020-08-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$35.64
Prev. Close
$35.34
Day Low
$35.17
Day High
$36.49
52W Low
$25.52
52W High
$40.87
Market Cap
$2.09B
Volume
0.33M
| 13.5 |
| 31 Dec 2023 | FY | 79.2% | 22.1% | 27.6% | 15.9% | 0.41 | 2.75 | 14.9 |
| 31 Dec 2022 | FY | 80.9% | 41.4% | 45.0% | 26.9% | 0.48 | 5.07 | 18.0 |
| 31 Dec 2021 | FY | 81.8% | 11.3% | 18.5% | 8.0% | 1.05 | 5.29 | 70.9 |
| 31 Dec 2020 | FY | 82.6% | -23.1% | -38.0% | -8.7% | 2.00 | 1.95 | -55.7 |
| 31 Dec 2019 | FY | 73.7% | -2535.1% | 1311.8% | -142.4% | -8.45 | 1.58 | -15.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -48.9% | -44.7% | 3.98 | 11.99 | -45.7 |
| 24.0 |
| 30 Sept 2025 | Q3 | 75.1% | 21.2% | 6.1% | 4.2% | 0.20 | 3.75 | 7.9 |
| 30 Jun 2025 | Q2 | 81.0% | 19.8% | 5.1% | 3.6% | 0.22 | 3.84 | 11.4 |
| 31 Mar 2025 | Q1 | 82.7% | 24.7% | 6.3% | 4.3% | 0.25 | 3.67 | 10.4 |
| 31 Dec 2024 | Q4 | 73.0% | 24.6% | 7.5% | 5.0% | 0.28 | 3.31 | 9.9 |
| 30 Sept 2024 | Q3 | 77.0% | 24.8% | 7.7% | 5.0% | 0.31 | 3.24 | 12.3 |
| 30 Jun 2024 | Q2 | 81.4% | 6.7% | 2.2% | 1.4% | 0.35 | 3.13 | 37.3 |
| 31 Mar 2024 | Q1 | 82.2% | 24.8% | 7.4% | 4.5% | 0.37 | 3.11 | 12.2 |
| 31 Dec 2023 | Q4 | 74.4% | 15.8% | 5.7% | 3.3% | 0.42 | 2.75 | 17.7 |